MediMarwan: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MediMarwan
Largest movements
- Cash +€88,431
up €88,431 (+17686.2%), from €500 to €88,931
mainly Net result for the year (+€68,304) and Receivables within one year (+€18,085)
- Receivables within one year -€18,085
down €18,085 (-23.6%), from €76,689 to €58,604
of which Other amounts receivable: -€16,507
- Deferred charges and accrued income -€2,340
down €2,340 (-18.8%), from €12,460 to €10,120
- Profit (loss) carried forward +€67,471
up €67,471 (+87.6%), from €77,050 to €144,521
- Gross operating margin -€8,529
down €8,529 (-8.9%), from €95,881 to €87,352
- Depreciation +€3,391
up €3,391 (+1362.5%), from €249 to €3,639
- Financial income +€1,347
up €1,347 (+59.2%), from €2,276 to €3,623
- Taxes -€1,168
down €1,168 (-5.8%), from €19,999 to €18,831
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €98,408 | €164,942 | +€66,534 | +67.6% |
| Fixed assets | 21/28 | €8,759 | €7,288 | -€1,471 | -16.8% |
| Tangible fixed assets | 22/27 | €8,759 | €7,288 | -€1,471 | -16.8% |
| Furniture and vehicles | 24 | €8,759 | €7,288 | -€1,471 | -16.8% |
| Current assets | 29/58 | €89,649 | €157,655 | +€68,006 | +75.9% |
| Amounts receivable within one year | 40/41 | €76,689 | €58,604 | -€18,085 | -23.6% |
| Trade receivables | 40 | €1,578 | - | -€1,578 | |
| Other amounts receivable | 41 | €75,111 | €58,604 | -€16,507 | -22.0% |
| Cash at bank and in hand | 54/58 | €500 | €88,931 | +€88,431 | +17686.2% |
| Deferred charges and accrued income | 490/1 | €12,460 | €10,120 | -€2,340 | -18.8% |
| Total equity and liabilities | 10/49 | €98,408 | €164,942 | +€66,534 | +67.6% |
| Equity | 10/15 | €77,550 | €145,021 | +€67,471 | +87.0% |
| Contributions | 10/11 | €500 | €500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €77,050 | €144,521 | +€67,471 | +87.6% |
| Amounts payable | 17/49 | €20,858 | €19,921 | -€937 | -4.5% |
| Amounts payable within one year | 42/48 | €20,858 | €19,921 | -€937 | -4.5% |
| Trade debts | 44 | - | €257 | +€257 | |
| Suppliers | 440/4 | - | €257 | +€257 | |
| Taxes, remuneration and social security | 45 | €19,999 | €18,831 | -€1,168 | -5.8% |
| Taxes | 450/3 | €19,999 | €18,831 | -€1,168 | -5.8% |
| Other amounts payable | 47/48 | €859 | €833 | -€26 | -3.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €249 | €3,639 | +€3,391 | +1362.5% |
| Gross operating margin | 9900 | €95,881 | €87,352 | -€8,529 | -8.9% |
| Operating profit (loss) | 9901 | €95,632 | €83,713 | -€11,919 | -12.5% |
| Financial income | 75/76B | €2,276 | €3,623 | +€1,347 | +59.2% |
| Recurring financial income | 75 | €2,276 | €3,623 | +€1,347 | +59.2% |
| Financial charges | 65/66B | - | €201 | +€201 | |
| Recurring financial charges | 65 | - | €201 | +€201 | |
| Profit (loss) for the period before taxes | 9903 | €97,908 | €87,135 | -€10,773 | -11.0% |
| Income taxes | 67/77 | €19,999 | €18,831 | -€1,168 | -5.8% |
| Profit (loss) for the period | 9904 | €77,909 | €68,304 | -€9,605 | -12.3% |
| Profit (loss) for the period to be appropriated | 9905 | €77,909 | €68,304 | -€9,605 | -12.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.